Healthy men test new version of cancer drug
NCT ID NCT06687928
First seen Apr 29, 2026 · Last updated May 19, 2026 · Updated 7 times
Summary
This study tested a new drug called CT-P6 against the approved drug Herceptin in 200 healthy men. The goal was to see if the body processes both drugs similarly and to check for side effects. Participants received a single injection under the skin.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celltrion
Yeonsu-gu, Incheon, 22006, South Korea
Conditions
Explore the condition pages connected to this study.